Soliton Inc.

Feb 06, 2020

Soliton Advances Market Launch Preparation; Appoints James Bucher as Senior Sales Consultant

Dec 10, 2019

Soliton Appoints Mary Stoll as Senior Director of Clinical Development

Dec 03, 2019

Soliton Initiates Significant Step Towards Commercialization

Aug 05, 2019

Soliton Partners with Clear Dermatology and Aesthetics Center to Advance Pivotal Cellulite Trial

Jul 23, 2019

Soliton's FDA Cleared Device is Granted Key Patent

Jul 08, 2019

Soliton to Announce Cellulite Trial Data for 26-Week Period on July 15, 2019

Jul 01, 2019

Soliton Partners with Capital Laser and Skin Care to Advance Pivotal Cellulite Trial

Jun 28, 2019

Soliton's Inclusion in the Russell 2000 and 3000 will be Effective After the Close of the Market Today

May 28, 2019

Soliton Receives FDA 510(k) Clearance of its Acoustic Shockwave RAP Device

May 16, 2019

Soliton's RAP Device Able to Penetrate Vacuole Shielding; Targets $4 Billion Potential Tattoo Removal Market

Apr 04, 2019

Soliton Receives European Patent for Acoustic Shockwave Technology

Mar 18, 2019

Soliton to Present at Oppenheimer 29th Annual Healthcare Conference on March 20, 2019